Dr. Zoltan Takacs uses a ThinkPad to analyze some of the world's deadliest toxins and turn them into medicine leads.
Most people avoid venomous creatures. Dr. Zoltan Takacs has spent his life chasing them.
The renowned scientist and explorer seeks out the venoms of some of the world’s deadliest creatures — snakes, spiders, scorpions and more — with the hope that their lethal toxins will provide a template for designing new medicines. The basic logic behind his method: What can kill you just might save your life.
Here are the top five things Medtronic learned from the pandemic and why we won’t forget.
When news of a mysterious, pneumonia-like disease spreading in China first broke in early 2020, few realized life was about to change for everyone. But that’s exactly what happened as cases of COVID-19 erupted everywhere and caused a global health pandemic.
Research shows ESG performance is strongly predictive of long-term value creation and financial performance, when a sector-specific approach is maintained
NEW YORK, March 22, 2021 /3BL Media/-As the world begins to emerge from under the weight of multiple crises, investors are seeking more effective and efficient ESG (environment, social, governance) communications directly from companies, which include a longer-term strategy and vision.
Even as COVID-19 vaccinations ramp up across the United States, many Americans still struggle to find appointments. As President Biden adds to the pressure on states by directing them to make all adults eligible for the COVID-19 vaccine by May 1, the private sector is moving in to help. This week, we examine how brands are utilizing their resources and teaming up to work toward putting an end to the pandemic.
The speed at which COVID-19 vaccines have been developed and produced hasn’t been matched by society’s ability to administer doses. As of this writing, 30 million doses delivered in the US have yet to be administered.
2020 was an extraordinary year – unlike most of us have ever seen before. Throughout the COVID-19 pandemic, many of us have faced both professional and personal challenges in adapting to our new reality. We’re looking beyond the science with two of Takeda’s leaders, Julie Kim, President of the Plasma-Derived Therapies Business Unit, and Rajeev Venkayya, President of the Vaccine Business Unit, to explore how Takeda adapted to this new normal while continuing to deliver for patients.
JAMA reports that people are drinking more since the start of the pandemic. Take a moment today to reach out to a friend, family member, neighbor, or colleague who may be struggling with Alcohol Use Disorder. Your support could impact their recovery journey.